These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6850733)

  • 1. [Metyrapone in the therapy of vitiligo].
    Dolecek R
    Cas Lek Cesk; 1983 May; 122(18):564-7. PubMed ID: 6850733
    [No Abstract]   [Full Text] [Related]  

  • 2. [Administration of metopirone in the treatment of vitiligo].
    Dolecek R
    Cas Lek Cesk; 1968; 107(38):1183-5. PubMed ID: 5682345
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vitiligo: its treatment with hypericin].
    Fujii HM; Pedroza AR; González W
    Prensa Med Argent; 1966 Aug; 53(33):1812-7. PubMed ID: 5994110
    [No Abstract]   [Full Text] [Related]  

  • 4. [Catamnesis of vitiligo patients].
    Lonshakov IuI
    Vestn Dermatol Venerol; 1985 Jan; (1):48-50. PubMed ID: 3976295
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vitiligo].
    Belova LV
    Med Sestra; 1985 Aug; 44(8):45-7. PubMed ID: 3851150
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
    Halder RM; Battle EF; Smith EM
    Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with the use of laser photochemotherapy in dermatology].
    Mandel' ASh
    Vestn Dermatol Venerol; 1985 Jul; (7):44-7. PubMed ID: 3901577
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical immunomodulators are effective for treatment of vitiligo.
    Choi CW; Chang SE; Bak H; Choi JH; Park HS; Huh CH; Kim CW; Kim SE; Mun SK; Kim BJ; Kim MN
    J Dermatol; 2008 Aug; 35(8):503-7. PubMed ID: 18789070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tacrolimus (FK506) 0.1% ointment WW in vitiligo in children and imperatives of combine therapy with Trioxsalen and Silymarin suspension in progressive vitiligo.
    Sehgal VN
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1218-9. PubMed ID: 19192018
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems of pathogenesis and treatment of vitiligo].
    Vedrova IN; Kriazheva SS; Udzhukhu VIu; Korotkiĭ NG
    Vestn Dermatol Venerol; 1987; (3):33-6. PubMed ID: 3037816
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide in vitiligo.
    Gokhale BB; Parakh AP
    Indian J Dermatol; 1983 Jan; 28(1):7-10. PubMed ID: 6852882
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of vitiligo with 1 percent solution of the sodium salt of meladinine using the ionophoresis technique.
    Badr Moawad M
    Dermatol Monatsschr; 1969; 155(6):388-94. PubMed ID: 5386750
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sulpiride in vitiligo].
    Cabre J
    Actas Dermosifiliogr; 1973; 64(11-12):617-20. PubMed ID: 4803658
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogenesis and treatment of vitiligo].
    Borisenko KK
    Vestn Dermatol Venerol; 1973 May; 47(5):11-6. PubMed ID: 4755955
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of vitiligo using oral Trisoralen].
    Karadaglić D; Stefanović Z; Mijailović B
    Zb Vojnomed Akad; 1976; (18):74-6. PubMed ID: 1074341
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcipotriene and corticosteroid combination therapy for vitiligo.
    Travis LB; Silverberg NB
    Pediatr Dermatol; 2004; 21(4):495-8. PubMed ID: 15283800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical melagenine for repigmentation in twenty-two child patients with vitiligo on the scalp.
    Xu AE; Wei XD
    Chin Med J (Engl); 2004 Feb; 117(2):199-201. PubMed ID: 14975202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of vitiligo in children with copper sulfate].
    Bagaeva MI
    Vestn Dermatol Venerol; 1979 Mar; (3):48-50. PubMed ID: 371236
    [No Abstract]   [Full Text] [Related]  

  • 19. [4-5-8 trimethylpsoralen in vitiligo. Controlled study of its therapeutic and toxic effect in children].
    Ruíz Maldonado R; Tamayo Sánchez L
    Actas Dermosifiliogr; 1975; 66(9-10):513-26. PubMed ID: 1199825
    [No Abstract]   [Full Text] [Related]  

  • 20. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.